Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Infusion of Third-party Mesenchymal Stem Cells After Renal or Liver Transplantation. A Phase I-II, Open-label, Clinical Study

NCT01429038 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT01429038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01429038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Infusion of Third-party Mesenchymal Stem Cells After Renal or Liver Transplantation. A Phase I-II, Open-label, Clinical Study
Lead sponsor
University of Liege
Phase
Phase 1/2
Overall status
Completed
Start date
February 1, 2012
Completion date
March 11, 2019
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure, liver failure